Bioiberica

Bioiberica is a global life science company dedicated to enhancing the well-being of humans, animals, and plants. With over 45 years of experience, the company has positioned itself as a leader in the production of heparin, the primary anticoagulant that saves around 100 million lives annually. Additionally, Bioiberica has established itself as a benchmark for the manufacture of APIs and functional ingredients for various sectors including pharmaceuticals, nutraceuticals, veterinary, animal nutrition, and agriculture.

The company's commitment to innovation in human, animal, and plant health is evident in its continuous efforts. Bioiberica's focus on partnership as a driver of success is particularly noteworthy, as it extends support to partners across global healthcare, plant, and animal health markets.

Founded in 1975, Bioiberica operates in the biotechnology and life sciences industries. The company's headquarters location and details about its latest investments and investors are not currently available.

For more information and updates on Bioiberica's initiatives, the company can be followed on their LinkedIn pages pertaining to animal health, human health, and plant health.